Wird geladen...
Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling
This study examined rates of genetic testing in two cohorts of publicly insured individuals who have newly prescribed medication with FDA pharmacogenomic labeling guidance. Genetic testing was rare (4.4% and 10.5% in Medicaid and Medicare cohorts, respectively) despite the fact that all participants...
Gespeichert in:
| Veröffentlicht in: | Pharmacogenomics J |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883752/ https://ncbi.nlm.nih.gov/pubmed/33589791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41397-021-00211-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|